Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Colonis Pharma Limited, Quantum House, Hobson Industrial Estate, Burnopfield, County Durham, NE16 6EA
Levothyroxine 25 micrograms/5ml Oral Solution.
| Pharmaceutical Form |
|---|
|
Oral Solution. Clear colourless, odourless solution. |
Each 5ml of oral solution contains 25 micrograms levothyroxine sodium.
Excipients with known effect:
Sodium methyl parahydroxybenzoate (E219): 10 mg per 5ml dose.
Glycerol: 3,780 mg per 5ml dose.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Levothyroxine |
Levothyroxine sodium is used for the treatment of hypothyroidism. The chief action of levothyroxine is to increase the rate of cell metabolism. |
| List of Excipients |
|---|
|
Glycerol |
Levothyroxine oral solution is packed in amber (Type III) glass bottle 100 ml, with child-resistant, tamper-evident screw cap with an LDPE liner, a 5ml graduated oral dosing syringe and a “press-in” syringe/bottle adaptor.
Colonis Pharma Limited, Quantum House, Hobson Industrial Estate, Burnopfield, County Durham, NE16 6EA
PL 41344/0031
24/10/2016
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
